What is the Vimta Labs PE ratio today?
Vimta Labs' PE ratio is 29.1 at the 29 October 2026 close (₹519.80 a share): a market capitalisation of ₹2,322 crore divided by standalone net profit of ₹79.7 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹77.5 crore) it is 30.0.
What is the Vimta Labs PB ratio (price to book value)?
Vimta Labs' price-to-book (PB) ratio is 5.08 at the 29 October 2026 close: a market capitalisation of ₹2,322 crore divided by shareholders' equity (book value) of ₹457 crore on 31 March 2026. That is a book value of ₹102.28 per share against a share price of ₹519.80.
What is the Vimta Labs net worth?
Vimta Labs' net worth — shareholders' equity in its standalone balance sheet — was ₹457 crore on 31 March 2026, up 20.6% from ₹379 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹2,322 crore at the 29 October 2026 close.
What is the Vimta Labs market cap?
Vimta Labs' market capitalisation was ₹2,322 crore at the 29 October 2026 close: 4.47 crore shares at ₹519.80 each.
What is the Vimta Labs EPS?
Vimta Labs' basic earnings per share (EPS) were ₹17.40 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹17.86.
What is the Vimta Labs dividend in 2026 and its record date?
In 2026, Vimta Labs has declared one dividend: ₹2 with record date 18 June 2026.
Is Vimta Labs debt free?
No. Vimta Labs had borrowings of ₹3.3 crore on 31 March 2026 (standalone balance sheet), a debt-to-equity ratio of 0.01. Its cash and current investments were ₹67.1 crore, so it held net cash of ₹63.7 crore.
What is the Vimta Labs debt to equity ratio?
Vimta Labs' debt-to-equity ratio was 0.01 on 31 March 2026: borrowings of ₹3.3 crore against total equity of ₹457 crore. A year earlier, on 31 March 2025, it was 0.02.
What is the Vimta Labs book value per share?
Vimta Labs' book value per share was ₹102.28 on 31 March 2026: shareholders' equity of ₹457 crore divided by the 4.47 crore shares in issue. The share price at the 29 October 2026 close was ₹519.80.
What is the Vimta Labs ROE and ROCE?
In FY26, Vimta Labs' return on equity (ROE) was 18.6% and its return on capital employed (ROCE) was 21.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 19.4% and ROCE 23.3%.
What is the Vimta Labs shareholding pattern?
On 30 September 2026, Vimta Labs' shares were held by promoters 35.64%, foreign portfolio investors (FII/FPI) 5.07%, domestic institutions (DII) 0.48% (including mutual funds at 0.23%) and retail and other non-institutional investors 58.80%. Over the year, FII holding was up 0.74 percentage points from 4.33% and DII holding was down 0.39 percentage points from 0.87%.
How does Vimta Labs compare with its peers?
On FY26 standalone figures, against Suven Life Sciences and TAKE: Vimta Labs' return on equity of 18.6% is the highest of the three (Suven Life Sciences −4.8%, TAKE 10.0%; peer average 2.6%); its revenue growth over three years of 8.9% a year is the highest of the three (Suven Life Sciences −19.3% a year, TAKE −51.0% a year; peer average −35.1% a year).
What is the Vimta Labs dividend yield?
Vimta Labs' dividend yield is 0.38% at the 29 October 2026 close: dividends of ₹2 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹519.80. They were ₹2 on 18 June 2026.
What is the Vimta Labs promoter holding?
Promoters held 35.64% of Vimta Labs on 30 September 2026, down 0.03 percentage points from 35.67% the previous quarter and down 0.35 percentage points from 35.99% a year earlier, according to the shareholding pattern filed with NSE.
What is the Vimta Labs free cash flow?
In FY26, Vimta Labs generated ₹147 crore of cash from operations and spent ₹99.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹47.3 crore. In FY25 it was ₹15.1 crore.
What are the Vimta Labs latest quarterly results?
Vimta Labs' latest results are for Q1 FY27 (April–June 2026), filed on 20 July 2026: standalone net profit ₹21 crore, up 11.4% from ₹18.9 crore in Q1 FY26; revenue from operations ₹109 crore, up 11.8% year on year.
What is the Vimta Labs revenue and profit in FY26?
In FY26 (April 2025–March 2026), Vimta Labs' standalone net profit was ₹77.5 crore, up 15.1% from ₹67.3 crore in FY25, on revenue from operations of ₹407 crore (up 18.4%). Over three years, from FY23, net profit was up 63.9%.
When are the Vimta Labs next results?
Vimta Labs will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, the date of the board meeting it has notified to the exchanges.
Vimta Labs vs Suven Life Sciences: how do they compare?
In FY26, Vimta Labs earned net profit of ₹77.5 crore on revenue of ₹407 crore, against ₹54.9 crore on ₹7.1 crore for Suven Life Sciences. Vimta Labs' operating margin was 24.0% (Suven Life Sciences −964.4%) and its return on equity 18.6% (Suven Life Sciences −4.8%). At the 29 October 2026 close, Vimta Labs' market capitalisation was ₹2,322 crore against ₹6,975 crore for Suven Life Sciences.
Standalone figures from the company's filings with NSE; prices are NSE closing prices.
